Prevention of Incisional Hernia With Mesh-suture at Umbilical Trocar Site.

NCT06251583 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 124

Last updated 2024-02-09

No results posted yet for this study

Summary

Incisional hernia related to the umbilical trocar site is probably the most frequent complication after laparoscopic surgical procedures. However, this is an underestimated sequelae of laparoscopic surgery which may involve an important morbidity and an increase in healthcare costs.

The incidence of incisional trocar site hernia ranges from 20 to 35% of patients after laparoscopic surgery depending on the different investigations. Prophylactic meshes have been tried in an attempt to reduce the incidence of this complication in obese patients. In that sense, suture-meshes can be an alternative to conventional meshes to improve the incidence of incisional hernias.

INDURATE TRIAL aims to test if suture-mesh is capable of reducing the incidence of incisional hernia in patients with risk factors for the development of this frequent complication when compared with conventional monofilament sutures.

Conditions

  • Incisional Hernia of Anterior Abdominal Wall
  • Dehiscence Wound
  • Wound Infection

Interventions

DEVICE

duramesh suture

Duramesh-suture will be used for trocar closure in the experimental group

Sponsors & Collaborators

  • Ana Sánchez Gollarte

    collaborator UNKNOWN
  • Álvaro Robin Valle de Lersundi

    collaborator UNKNOWN
  • Arturo Cruz Cidoncha

    collaborator UNKNOWN
  • Almudena Moreno Elola-Olaso

    collaborator UNKNOWN
  • Armando Galván Pérez

    collaborator UNKNOWN
  • Ana María Minaya Bravo

    collaborator UNKNOWN
  • Enrique González González

    collaborator UNKNOWN
  • Carlos Guijarro Moreno

    collaborator UNKNOWN
  • Asunción Aguilera Velardo

    collaborator UNKNOWN
  • Patricia López Quindos

    collaborator UNKNOWN
  • Clara María Martínez Moreno

    collaborator UNKNOWN
  • Marina Pérez-Flecha González

    collaborator UNKNOWN
  • Victor Vaello Jodra

    collaborator UNKNOWN
  • Miguel A ngel Garci-a Urena

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-22
Primary Completion
2024-03-22
Completion
2025-06-30
FDA Device
Yes

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06251583 on ClinicalTrials.gov